Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Device
- Surgical
- Medical
- Laser
- Electro Medical/ Elector therapeutic
- Scientific & Technical Instruments
- cardiac
- Disposable
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 7744
License Grant
Licensor desires to license exclusive manufacturing rights and exclusive marketing rights for this device, including any derivative devices, substantially conforming to the specifications as well as the exclusive right to use its mark EX-308 on devices RA intends to manufacture and market.
License Property
Licensor has received clearances from the US Food and Drug Administration denominated 510K k993328 and k020973, to market a laser device having certain specifications.
EX-308 Excimer Laser is the name applied to any product cleared to market by the FDA under 510k k993328 and k020973 and bearing the mark 'EX-308'.
Field of Use
PHAROS excimer lasers are xenon chloride (XeCl) lasers that deliver concentrated, high-dose monochromatic 308nm UVB phototherapy directly to psoriatic and depigmented lesions limiting exposure to surrounding healthy tissue. Unlike conventional UVB systems that emit wavelengths from 290 to 320nm, PHAROS excimer lasers deliver only monochromatic 308nm, an efficacious wavelength for treating psoriasis, vitiligo, atopic dermatitis, and leukoderma.
IPSCIO Record ID: 118680
License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue. The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.
IPSCIO Record ID: 158782
License Grant
Pursuant to a prior employment agreement, the Licensor, of Japan and residing in the U.S. and the Licensee have a contractual agreement for patents.
License Property
The patents are for Contact Laser(TM) Probes and Scalpels and Contact Fibers, Heraeus LaserBlade(TM) Scalpels and Contact Fibers, HSI conical contact fibers.
'Contact Laser(TM) Patents' means the following three U.S. Patent Nos. 4,693,244; 4,592,353; and 4,736,743.
Field of Use
Licensee's Contact Laser(TM) System, unlike conventional laser systems, enables the surgeon to use the laser instrument in direct contact with the tissue being treated, thereby significantly enhancing the ease of use and precision of laser surgery in many applications.
IPSCIO Record ID: 233464
License Grant
Licensor grants a non-exclusive, worldwide license, without the right to sublicense, to make, have made, use, import, sell, offer for sale, or otherwise dispose of Licensed Products, and to practice any method or process involved in the manufacture, testing or use thereof, under the Licensed Licensor Patents.
License Property
Licensor is the exclusive licensee of U.S. Patent No. 4,784,135 and No. 4,686,979.
The Licensed Products means Lasers, and, Disposables. Laser shall mean any source of amplified, coherent light having a wavelength between 100 and 400 nanometers. Disposable shall mean apparatus comprised, at least in part, or one of more optical fibers, that is or may be coupled to a Laser, as hereinafter defined, to guide the light emitted from that Laser to a treatment location within a human or animal body. Such apparatus shall fall within the definition of Disposable irrespective of whether it is intended for use in more than one procedure.
Field of Use
This agreement is for the field of transmyocardial revascularization or percutaneous transmyocardial revascularization.
Transmyocardial laser revascularization (TMR) is a procedure used to treat inoperable heart disease in people with persistent angina that isn't relieved by any other revascularization method.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
